Withdrawal of clinical trials policy by Canadian research institute is a "lost opportunity for increased transparency"
Silversides, A.
Bmj 342: D2570
2011
ISSN/ISBN: 0959-8138 PMID: 21511787 Document Number: 654807
Document emailed within 1 workday
Related Documents
Urrutia, G.; Bonfill, X.; Martí, J. 1999: In search of lost evidence. Proposals for increasing the transparency of clinical trials Medicina Clinica 112(Suppl 1): 21-27Nicolucci, A.; Grilli, R.; Alexanian, A.A.; Apolone, G.; Torri, V.; Liberati, A. 1989: Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis JAMA 262(15): 2101-2107
Lacey, C.; Scodras, S.; Ardron, J.; Sellan, R.; Garbaczewska, M.; O'Brien, K.K.; Salbach, N.M. 2018: Retrospective Review of Student Research Projects in a Canadian Master of Science in Physical Therapy Programme and the Perceived Impact on Advisors' Research Capacity, Education, Clinical Practice, Knowledge Translation, and Health Policy PhysioTherapy Canada. Physiotherapie Canada 70(2): 160-168
Dencker, S.J.; Elgen, K. 1980: Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
Cairns, J.A. 2004: The Canadian Clinical Research Initiative: transforming Canadian clinical research capacity Clinical and Investigative Medicine. Medecine Clinique et Experimentale 27(6): 292-295
Vallance, K.; Stockwell, T.; Wettlaufer, A.; Giesbrecht, N.; Chow, C.; Card, K.G.; Farrell-Low, A. 2022: Strategies for engaging policy stakeholders to translate research knowledge into practice more effectively: Lessons learned from the Canadian Alcohol Policy Evaluation project Drug and Alcohol Review 41(1): 246-255
Sherman, P.M.; Makarchuk, M-Jo.; Belanger, P.; Roberts, E.A. 2011: Strategic plan of the Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes Canadian Journal of Gastroenterology 25(10): 560-564
Ruel, M.T.; Brown, K.H.; Caulfield, L.E. 2003: Moving forward with complementary feeding: indicators and research priorities. International Food Policy Research Institute (IFPRI) discussion paper 146 (April 2003) Food and Nutrition Bulletin 24(3): 289-290
Russell, T.R. 2008: From my perspective. The establishment of a new Health Policy and Research Institute Bulletin of the American College of Surgeons 93(11): 4-5
Mben, J-Marc.; Kouanfack, C.; Essomba, C.Ntsama.; Mbougua, J.Brice.Tchatchueng.; Kenfack, A.; Tonfack, Cément.Auguste.Djouatsa.; Laborde-Balen, Gèle.; Bourgeois, A.; Biwolé-Sida, M.; Delaporte, E.; Laurent, C. 2012: Operational research and HIV policy and guidelines: lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon Journal of Public Health Policy 33(4): 462-477
Moyé, L.A.; Powell, J.H. 2001: Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered Journal of the National Medical Association 93(12 Suppl): 29S-34S
Anonymous 1965: Indian Agricultural Research Institute, New Delhi. Indian Institute of Sugarcane Research, Lucknow. Central Coconut Research Station, Kayangulam Jabalpur Agric. Res. New Delhi. New Delhi, India: 5(3): 225-226
Oldenbroek, J.K.; Garssen, G.J. 1990: Effect of BST administration on milk production and metabolism of dairy cows in 3 consecutive years of IVO trials(Institute for Animal Husbandry Research) Tijdschrift Voor Diergeneeskunde 115(13): 613-624
Schück, O. 2002: History of the Institute for Clinical and Experimental Medicine (IKEM), a research institute for experimental therapy Casopis Lekaru Ceskych 141(7): 226-227
Lenfant, C. 2002: Strengthening commitment to clinical research: The National Heart, Lung, and Blood Institute's Specialized Centers of Research program Circulation 105(4): 400-401
Ivy, S.Percy.; Ivy, S.Percy. 2015: The National Cancer Institute's Experimental Therapeutics Clinical Trials Network Clinical Advances in Hematology and Oncology: H&o 13(3): 144-146
Levin, A. 2001: Reporting standards and the transparency of trials Annals of Internal Medicine 134(2): 169-172
Conn, J. 2011: Lost opportunity? Extension to speed EHR adoption too late for some Modern Healthcare 41(49): 12
Orlando, C.P. 1992: DUE uncovers lost opportunity for savings in laboratory costs American Journal of Hospital Pharmacy 49(3): 561-562
Mack, N.; Ramirez, C.B.; Friedland, B.; Nnko, S. 2013: Lost in translation: assessing effectiveness of focus group questioning techniques to develop improved translation of terminology used in HIV prevention clinical trials Plos one 8(9): E73799